| 4/8/2025 | SP | New Issue: UBS prices $10 million phoenix autocallable buffer notes linked to Merck
|
| 4/4/2025 | SP | New Issue: Citigroup prices $3.6 million autocallable securities linked to Merck
|
| 3/30/2025 | SP | New Issue: Citigroup prices $12 million 18% autocallable phoenix securities linked to Merck
|
| 3/24/2025 | BKGNIG | Moody's boosts Merck notes, loan
|
| 3/13/2025 | SP | New Issue: RBC prices $1.99 million autocallable contingent coupon barrier notes on Merck
|
| 3/12/2025 | SP | New Issue: BofA prices $2.5 million 9.35% contingent income autocallables linked to Merck, S&P
|
| 3/4/2025 | SP | New Issue: Morgan Stanley prices $6.1 million contingent income autocallables linked to Merck
|
| 2/26/2025 | SPSW | Structured notes tally $566 million for week; stock-linked notes, fixed-rate trades eyed
|
| 2/25/2025 | SP | New Issue: UBS prices $10 million phoenix autocallable buffer notes linked to Merck
|
| 2/24/2025 | SP | New Issue: Citigroup prices $10 million 18% autocallable phoenix notes tied to Merck
|
| 2/24/2025 | SP | New Issue: Citigroup prices $10 million 18% autocallable phoenix securities linked to Merck
|
| 1/28/2025 | SP | New Issue: UBS prices $1.7 million trigger autocallable contingent yield notes on Merck
|
| 12/20/2024 | SP | New Issue: UBS prices $8 million of 7.5% capped buffered yield notes linked to Merck
|
| 12/16/2024 | SP | New Issue: Citigroup prices $1.07 million 10.2% callable contingent coupon notes linked to Merck
|
| 11/14/2024 | SP | New Issue: Barclays sells $3.46 million phoenix autocallable notes linked to four stocks
|
| 8/22/2024 | SP | New Issue: JPMorgan prices $1.43 million return notes linked to basket of 20 stocks
|
| 8/4/2024 | SP | New Issue: Citigroup prices $350,000 7.5% autocallable contingent coupon notes on stock, ETF
|
| 6/27/2024 | SP | New Issue: Citi prices $148,000 7.8% contingent coupon autocallables linked to Merck, utilities ETF
|
| 5/16/2024 | BKEUGNIG | Moody's assigns A1 to Merck unit notes
|
| 5/2/2024 | SP | New Issue: BMO sells $577,000 autocallable barrier notes with contingent coupons on Merck
|
| 4/18/2024 | SP | New Issue: Citigroup prices $778,000 7.7% autocallable contingent coupon notes on stock, ETF
|
| 4/8/2024 | BKGNIG | Moody’s revises Merck view to positive
|
| 2/23/2024 | SP | New Issue: Barclays prices $680,000 autocallable fixed coupon notes on three stocks
|
| 2/11/2024 | SP | New Issue: JPMorgan prices $250,000 8.5% autocallable contingent interest notes on stocks
|
| 11/27/2023 | SP | New Issue: HSBC prices $970,000 17.3% contingent income barrier autocallables with memory on stocks
|
| 10/27/2023 | SP | New Issue: UBS sells $5.2 million trigger autocallable contingent yield notes with memory on stocks
|
| 9/19/2023 | SP | New Issue: RBC prices $1.45 million levered market plus notes linked to stock basket
|
| 8/31/2023 | SP | New Issue: UBS sells $2.33 million capped trigger gears on basket of 40 stocks
|
| 7/17/2023 | SP | New Issue: JPMorgan sells $3.21 million trigger autocallable contingent yield notes on Merck
|
| 6/28/2023 | SP | New Issue: JPMorgan prices $1.58 million return notes linked to basket of 20 stocks
|
| 5/30/2023 | SP | New Issue: Citigroup prices $2.32 million 8% autocallable equity linked securities linked to Merck
|
| 5/19/2023 | SP | New Issue: JPMorgan prices $563,000 7.5% autocallable contingent interest notes linked to Merck
|
| 5/12/2023 | IG | Market Commentary: Strong high-grade supply expected in week ahead; new issues firm; inflows heavy
|
| 5/9/2023 | IG | New Issue: Merck prices $6 billion fixed-rate notes in six tranches
|
| 5/8/2023 | GNIG | Moody’s gives A1 to Merck notes
|
| 5/8/2023 | GNIG | S&P rates Merck notes A+
|
| 5/8/2023 | IG | Merck to sell six tranches of notes for Prometheus acquisition
|
| 4/17/2023 | BKIG | Merck touts options for $10.8 billion acquisition of Prometheus
|
| 3/24/2023 | GNIG | Moody’s changes Merck outlook to stable
|
| 1/24/2023 | SP | New Issue: CIBC prices $1.05 million Accelerated Return Notes on basket of healthcare stocks
|
| 1/17/2023 | SP | New Issue: JPMorgan sells $2.13 million capped accelerated barrier notes on basket of 10 stocks
|
| 1/17/2023 | SP | New Issue: JPMorgan sells $3.02 million capped accelerated barrier notes on basket of 10 stocks
|
| 1/11/2023 | SPSW | First week of 2023 kicks off with $309 million of reported structured notes issuance
|
| 12/30/2022 | IG | Market Commentary: Outlook 2023: High-grade bond market braces for lower deal supply, tighter credit spreads
|
| 12/21/2022 | SPSW | Structured products issuance $356 million for week; $70 million cash-settled deal eyed
|
| 11/7/2022 | SP | New Issue: UBS prices $1.81 million trigger autocallable contingent yield notes on four stocks
|
| 10/5/2022 | SPSW | BofA prices jumbo deals as weekly structured products tally hits $1.85 billion
|
| 7/19/2022 | SP | New Issue: UBS sells $500,000 step down trigger autocallable notes on Merck, Microsoft, Apple
|
| 7/15/2022 | SP | New Issue: JPMorgan sells $1.01 million trigger autocallable contingent yield notes on Merck
|
| 7/13/2022 | SPSW | Issuance volume, deal count drops in first half of the year, the worst for equities since 1970
|
| 6/29/2022 | SPSW | Structured products issuance $1.1 billion for week; big $368 million Boeing-linked deal eyed
|
| 6/17/2022 | IG | Market Commentary: Deal volume hits roadblock over Fed week; IG names trading at ‘distressed levels’
|
| 6/17/2022 | SP | New Issue: Credit Suisse prices $1 million capped notes tied to stock basket
|
| 6/16/2022 | SP | New Issue: CIBC sells $1.2 million of 7.08% fixed-interest barrier notes on three stocks
|
| 6/16/2022 | SP | New Issue: Morgan Stanley prices $1.49 million 9.26% contingent income autocalls on Alphabet, BlackRock, Microsoft, Merck
|
| 5/25/2022 | SP | Market Commentary: BofA’s $530.45 million cash-settled notes on Merck puzzle sellsiders due to size, payoff
|
| 5/25/2022 | SPSW | Structured products tally nears $1 billion for week boosted by $515 million deal
|
| 5/23/2022 | SP | New Issue: BofA sells $530.45 million cash-settled equity-linked notes on Merck
|
| 2/16/2022 | SP | New Issue: BMO sells $2.59 million enhanced return notes on stock basket
|
| 2/16/2022 | SP | New Issue: BMO sells $2.6 million buffer enhanced return notes on stock basket
|
| 1/12/2022 | SP | New Issue: UBS prices $4.62 million trigger autocallable contingent yield notes on Merck
|
| 12/8/2021 | GNIG | New Issue: Merck details $8 billion sale of notes in five parts, including sustainability notes
|
| 12/7/2021 | IG | New Issue: Merck sells $8 billion offering of senior notes in five parts
|
| 12/7/2021 | GN | New Issue: Merck sells $1 billion of 1.9% sustainability notes due 2028
|
| 12/7/2021 | SP | New Issue: HSBC sells $710,000 contingent income barrier autocalls on Gilead, Amgen, Merck
|
| 12/7/2021 | GNIG | Merck to sell notes in five parts, including one tranche of sustainability notes; talk emerges
|
| 12/7/2021 | GNIG | Merck plans to sell notes in five tranches, including one tranche of sustainability notes
|
| 12/7/2021 | GNIG | Moody's assigns A1 to Merck notes
|
| 12/3/2021 | SP | New Issue: UBS prices $735,000 trigger phoenix autocallables linked to Merck
|
| 10/1/2021 | IG | Moody’s turns Merck view to negative
|
| 9/24/2021 | SP | New Issue: UBS prices $4.7 million trigger autocallable contingent yield notes on Merck
|
| 8/10/2021 | SP | New Issue: UBS sells $894,000 trigger autocallable contingent yield notes add-on on pharma stocks
|
| 8/6/2021 | SP | New Issue: Citigroup sells $1.7 million equity-linked securities on three stocks
|
| 7/22/2021 | SP | New Issue: Barclays sells $500,000 autocallable contingent coupon notes on stocks
|
| 6/9/2021 | SP | New Issue: UBS prices $3 million trigger autocallable contingent yield notes on pharma stocks
|
| 6/3/2021 | IG | S&P cuts Merck & Co.
|
| 6/2/2021 | SP | New Issue: UBS sells $2.9 million trigger autocallable contingent yield notes on Merck
|
| 5/28/2021 | SP | New Issue: JPMorgan sells $6.6 million yield notes on Merck
|
| 5/26/2021 | SP | New Issue: UBS prices $50 million exchangeable notes linked to Merck
|
| 4/21/2021 | SP | New Issue: UBS prices $625,000 trigger phoenix autocallables tied to Merck
|
| 4/21/2021 | SP | New Issue: UBS prices $700,000 trigger phoenix autocallables linked to Merck
|
| 4/21/2021 | SP | New Issue: UBS prices $625,000 trigger phoenix autocallables linked to Merck
|
| 3/21/2021 | SP | New Issue: Credit Suisse sells $6.59 million autocallable contingent income notes on pharma stocks
|
| 3/8/2021 | SP | New Issue: GS Finance increases equity-linked notes on Merck to $36.8 million
|
| 2/23/2021 | SP | New Issue: GS Finance sells $32 million equity-linked notes on Merck
|
| 2/21/2021 | SP | New Issue: Citi sells $1.93 million autocallable contingent coupon equity notes on three stocks
|
| 1/14/2021 | SP | New Issue: Credit Suisse sells $2.56 million autocallable reverse converts on stocks
|
| 12/29/2020 | SP | New Issue: GS Finance sells $1.71 million leveraged basket-linked notes on 23 stocks
|
| 12/26/2020 | SP | New Issue: GS Finance sells $500,000 leveraged basket-linked notes on 37 stocks
|
| 11/20/2020 | SP | New Issue: Credit Suisse sells $466,000 contingent coupon autocallable reverse converts on stocks
|
| 10/26/2020 | SP | New Issue: Credit Suisse sells $2.83 million contingent coupon autocallable yield notes on stocks
|
| 9/23/2020 | SPSW | Structured products agents price $390 million during week amid third week of tech sell-off
|
| 9/18/2020 | SP | New Issue: Credit Suisse prices $59.8 million equity-linked notes tied to Merck
|
| 9/18/2020 | SP | New Issue: Credit Suisse prices $15.2 million equity-linked notes tied to Merck
|
| 9/2/2020 | SP | New Issue: Credit Suisse sells $1.96 million autocallable reverse converts on three stocks
|
| 8/18/2020 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Merck
|
| 8/14/2020 | SP | New Issue: UBS sells $5 million airbag autocallable yield notes on Merck
|
| 6/24/2020 | SP | New Issue: UBS prices $525,000 trigger phoenix autocallables linked to Merck
|
| 6/24/2020 | SP | New Issue: UBS prices $475,000 trigger phoenix autocallables linked to Merck
|
| 6/24/2020 | SP | New Issue: UBS prices $400,000 trigger phoenix autocallables linked to Merck
|
| 6/19/2020 | IG | Fitch rates Merck notes A+
|
| 6/17/2020 | IG | Market Commentary: High-grade volume heavy; Upjohn, NetApp, GM, Schlumberger in primary; Ford Foundation on tap
|
| 6/17/2020 | IG | Market Commentary: Morning Commentary: High-grade volume heavy; Upjohn, NetApp, GM, Barclays on deck
|
| 6/16/2020 | EMHYPFPV | Market Commentary: Pacific Gas, Bank of America, Merck, Danske, BorgWarner, Perrigo price
|
| 6/16/2020 | IG | Market Commentary: Pacific Gas, Bank of America, Merck, Danske, BorgWarner, Perrigo, Welltower, Wabtec price
|
| 6/16/2020 | IG | New Issue: Merck prices $4.5 billion four-tranche offering of fixed-rate notes
|
| 6/16/2020 | IG | Moody’s gives Merck notes A1
|
| 6/16/2020 | IG | S&P assigns Merck notes AA-
|
| 6/16/2020 | IG | Market Commentary: Morning Commentary: High-grade supply climbs; Merck, Wabtec, BorgWarner, Perrigo on tap
|
| 6/16/2020 | IG | Merck plans to price notes in four parts via four bookrunners
|
| 6/11/2020 | SP | New Issue: UBS prices $750,000 trigger phoenix autocallables linked to Merck
|
| 5/27/2020 | SP | New Issue: UBS sells $1.84 million trigger autocallable contingent yield notes on Merck
|
| 5/14/2020 | SP | New Issue: JPMorgan sells $2.6 million autocallable yield notes on three stocks
|
| 3/26/2020 | SP | New Issue: Credit Suisse $1.62 million contingent coupon autocallable yield notes on four stocks
|
| 3/19/2020 | SP | New Issue: Credit Suisse sells $2 million 8% autocallable reverse convertibles on pharma stocks
|
| 3/13/2020 | SP | Credit Suisse to price contingent coupon autocallable yield notes on four stocks
|
| 3/6/2020 | SP | New Issue: RBC prices $739,000 contingent coupon barrier autocalls on three stocks
|
| 2/7/2020 | IG | Fitch affirms Merck
|
| 2/5/2020 | IG | S&P cuts Merck
|
| 1/22/2020 | SP | New Issue: Credit Suisse $4.68 million contingent coupon autocallable yield notes on pharma stocks
|
| 12/17/2019 | SP | New Issue: RBC sells $5.58 million trigger autocallable contingent yield notes on Merck
|
| 12/4/2019 | SP | New Issue: Credit Suisse sells $1.43 million autocallable yield notes on three stocks
|
| 10/4/2019 | SP | New Issue: UBS prices $3.9 million trigger autocallable contingent yield notes on stocks
|
| 9/30/2019 | SP | New Issue: UBS sells $4.05 million trigger autocallable contingent yield notes on Merck
|
| 9/19/2019 | SP | UBS plans trigger autocallable contingent yield notes on Merck
|
| 9/5/2019 | SP | New Issue: RBC sells $323,000 contingent coupon barrier autocalls on two stocks
|
| 8/20/2019 | SP | New Issue: Credit Suisse sells $2.52 million trigger autocallable contingent yield notes on Merck
|
| 8/15/2019 | SP | RBC plans contingent coupon barrier autocallables on two stocks
|
| 8/13/2019 | SP | New Issue: JPMorgan prices $2.33 million contingent interest autocallables linked to Rio Tinto, Merck, Intel
|
| 7/29/2019 | SP | New Issue: RBC sells $400,000 issuer callable contingent coupon barrier notes on ETF, stocks
|
| 7/18/2019 | SP | Credit Suisse to price trigger autocallable notes linked to Merck
|
| 5/28/2019 | SP | Credit Suisse to price buffered return equity notes on stock basket
|
| 5/21/2019 | SP | New Issue: Barclays prices $510,000 notes linked to pharmaceutical stocks
|
| 4/24/2019 | SP | Citibank to price variable coupon market-linked CDs tied to 10 stocks
|
| 4/23/2019 | SP | New Issue: UBS sells $1.37 million trigger autocallable contingent yield notes on Merck
|
| 4/18/2019 | SP | New Issue: UBS prices $1.22 million trigger phoenix autocallables linked to Merck
|
| 4/17/2019 | SP | UBS plans trigger autocallable contingent yield notes on Merck
|
| 3/12/2019 | SP | New Issue: RBC sells $100,000 contingent coupon barrier autocallables on two pharma stocks
|
| 3/8/2019 | EMHYPFPV | Market Commentary: Steady high-grade volume eyed; SoCal Edison holds calls; new issues mixed; CVS widens
|
| 3/8/2019 | IG | Market Commentary: Steady high-grade volume eyed; SoCal Edison holds calls; new issues mixed; CVS widens
|
| 3/8/2019 | IG | Market Commentary: Morning Commentary: SoCal Edison eyes market; Pfizer, Merck bonds mixed; inflows decline
|
| 3/6/2019 | SP | New Issue: Credit Suisse prices $5.54 million buffered PLUS tied to basket of 10 stocks
|
| 3/6/2019 | IG | New Issue: Merck details $5 billion sale of fixed-rate notes in four tranches
|
| 3/5/2019 | EMHYPFPV | Market Commentary: Merck, Lloyds, Lazard, Japan Finance price $7.5 billion of bonds; Dell, Cimarex eye market
|
| 3/5/2019 | IG | Market Commentary: Merck, Lloyds, Lazard, Japan Finance price $7.5 billion of bonds; Dell, Cimarex eye market
|
| 3/5/2019 | IG | New Issue: Merck prices $5 billion of fixed-rate notes in four tranches
|
| 3/5/2019 | IG | S&P rates Merck notes AA
|
| 3/5/2019 | IG | Moody's rates Merck notes A1
|
| 3/5/2019 | IG | Market Commentary: Morning Commentary: Merck, Lazard, Lloyds, Japan Finance on tap; Dell, Cimarex eye market
|
| 3/5/2019 | IG | Merck aims to price notes in four tranches via three bookrunners
|
| 2/11/2019 | SP | Credit Suisse to price buffered PLUS tied to basket of 10 stocks
|
| 1/8/2019 | SP | New Issue: Credit Suisse sells $445,000 trigger autocallable contingent yield notes on Merck
|
| 11/21/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 10/26/2018 | SP | New Issue: Barclays sells $633,000 14.5% buffered phoenix autocalls on stocks
|
| 10/24/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 10/23/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2025 on 10 stocks
|
| 10/23/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2023 on 10 stocks
|
| 10/17/2018 | SP | Barclays to price phoenix autocallables due 2022 tied to four stocks
|
| 9/24/2018 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
| 9/21/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 9/21/2018 | SP | New Issue: RBC sells $1.55 million 9.3% contingent coupon autocalls tied to three stocks
|
| 9/20/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2025 on 10 stocks
|
| 9/20/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2023 on 10 stocks
|
| 9/20/2018 | IG | Fitch upgrades Merck
|
| 8/27/2018 | SP | Citibank to price five-year market-linked CDs on basket of 10 stocks
|
| 8/24/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 8/23/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2025 on 10 stocks
|
| 8/23/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2023 on 10 stocks
|
| 7/24/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 7/23/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2025 on 10 stocks
|
| 7/23/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2023 on 10 stocks
|
| 7/19/2018 | SP | New Issue: Barclays prices $4.76 million 7% contingent yield trigger autocalls linked to Merck
|
| 7/16/2018 | SP | New Issue: Citigroup sells $1.94 million contingent coupon autocallables on Allergan, Merck
|
| 7/2/2018 | SP | Market Commentary: HSBC’s 10% autocall on pharma stocks: not a buy-and-hold, low-risk strategy, advisers say
|
| 6/29/2018 | SP | HSBC to price 10% autocallable yield notes on pharmaceutical stocks
|
| 6/19/2018 | SP | Citi plans 9% to 10% contingent coupon autocalls on Allergan, Merck
|
| 6/13/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2025 on 10 stocks
|
| 6/13/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2023 on 10 stocks
|
| 6/13/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 5/14/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 5/14/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2025 on 10 stocks
|
| 5/14/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2023 on 10 stocks
|
| 4/23/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2023 on 10 stocks
|
| 4/23/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2025 on 10 stocks
|
| 4/23/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 3/19/2018 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 3/19/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 10.75% potential coupon
|
| 3/19/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 5.5% potential coupon
|
| 3/19/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 5% potential coupon
|
| 3/19/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 9% potential coupon
|
| 3/19/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2023 on 10 stocks
|
| 3/19/2018 | SP | Goldman Sachs to price variable-coupon CDs due 2025 on 10 stocks
|
| 2/9/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 8.75% potential coupon
|
| 2/9/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 4.75% potential coupon
|
| 2/9/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 10.5% potential coupon
|
| 2/9/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 5.25% potential coupon
|
| 2/8/2018 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
| 1/31/2018 | SP | New Issue: Citigroup prices $3.57 million contingent coupon autocallables on Bristol-Myers, Merck
|
| 1/23/2018 | SP | New Issue: HSBC prices $5.12 million autocallable securities on Merck
|
| 1/11/2018 | SP | HSBC plans autocallable target income CDs linked to five stocks
|
| 1/11/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 8.75% potential coupon
|
| 1/11/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 4.5% potential coupon
|
| 1/11/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 10.75% potential coupon
|
| 1/11/2018 | SP | HSBC plans Income Plus CDs tied to stocks with 5% potential coupon
|
| 1/10/2018 | SP | Citigroup plans contingent coupon autocallables linked to two stocks
|
| 1/10/2018 | SP | New Issue: UBS prices $5.17 million trigger autocallable contingent yield notes tied to Merck
|
| 12/20/2017 | SP | New Issue: Barclays sells $813,000 two-year phoenix autocallables tied to four stocks
|
| 12/18/2017 | SP | Bank of the West plans contingent variable-income CDs on 10 stocks
|
| 12/18/2017 | SP | Bank of the West plans income advantage CDs linked to five stocks
|
| 12/13/2017 | SP | New Issue: Morgan Stanley sells $975,000 market-linked notes tied to 18 stocks
|
| 12/13/2017 | SP | New Issue: Morgan Stanley sells $510,000 market-linked notes tied to 18 stocks
|
| 12/11/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 12/4/2017 | SP | Market Commentary: RBC’s $1.37 million gears tied to basket of 29 stocks aim to reweight the Dow Jones Industrial
|
| 11/30/2017 | SP | New Issue: RBC sells $1.37 million buffer gears tied to basket of 29 stocks
|
| 11/21/2017 | SP | New Issue: HSBC prices $1.95 million 7.6% contingent income barrier autocalls tied to stocks
|
| 11/17/2017 | SP | New Issue: Credit Suisse sells $759,000 contingent coupon autocallables tied to three stocks
|
| 11/14/2017 | SP | New Issue: Credit Suisse prices $2.59 million 8% autocallable reverse convertibles on four pharma stocks
|
| 11/14/2017 | IGLM | Merck takes in tenders for $584.7 million of eight series in offer
|
| 11/13/2017 | SP | New Issue: Credit Suisse sells $4.89 million trigger autocallable contingent yield notes on Merck
|
| 11/13/2017 | SP | New Issue: GS Finance prices $1.6 million contingent coupon autocallables on Apple, Citi, Merck
|
| 11/13/2017 | IGLM | Merck determines pricing of tender offers for eight series of notes
|
| 11/9/2017 | SP | Credit Suisse plans 9.6% contingent coupon autocalls tied to stocks
|
| 11/6/2017 | IGLM | Merck begins one-week tender for $850 million of eight note series
|
| 11/2/2017 | SP | Credit Suisse plans contingent yield trigger autocallables on Merck
|
| 10/30/2017 | SP | New Issue: JPMorgan sells $1.75 million contingent interest autocallables tied to three stocks
|
| 10/26/2017 | SP | Goldman plans contingent 9%-10% four-year autocallables tied to stocks
|
| 10/19/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 10/19/2017 | SP | New Issue: RBC sells $400,000 six-year individually capped notes tied to 15 stocks
|
| 10/16/2017 | SP | JPMorgan plans contingent interest autocallables tied to three stocks
|
| 9/14/2017 | SP | New Issue: JPMorgan prices $1.45 million contingent buffer return enhanced notes tied to stocks
|
| 9/13/2017 | SP | Bank of the West plans contingent variable-income CDs on 10 stocks
|
| 8/18/2017 | SP | JPMorgan plans digital contingent coupon CDs linked to 10 stocks
|
| 8/18/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 8/18/2017 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
| 8/14/2017 | SP | New Issue: RBC prices $1 million contingent coupon barrier autocallables on Merck
|
| 7/26/2017 | SP | Market Commentary: Wells Fargo’s variable annual interest CDs tied to 10 stocks offer alternative to fixed income
|
| 7/24/2017 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
| 7/17/2017 | SP | New Issue: HSBC sells $1.55 million autocallable yield notes tied to three stocks
|
| 7/10/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 6/19/2017 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
| 5/22/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 5/22/2017 | SP | Wells Fargo plans variable annual interest CDs tied to 10 stocks
|
| 4/25/2017 | SP | New Issue: UBS prices $625,000 trigger phoenix autocallables linked to Merck
|
| 4/21/2017 | SP | Goldman Sachs to sell variable-coupon CDs due 2024 linked to 10 stocks
|
| 4/21/2017 | SP | Goldman Sachs plans variable-coupon CDs due 2024 tied to 10 stocks
|
| 4/21/2017 | SP | Goldman Sachs to price variable-coupon CDs due 2024 on 10 stocks
|
| 4/21/2017 | SP | Goldman Sachs to price variable-coupon CDs due 2022 on 10 stocks
|
| 4/21/2017 | SP | New Issue: Citigroup sells $3.35 million autocallable contingent coupon securities on two stocks
|
| 4/20/2017 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 4/17/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 3/15/2017 | SP | New Issue: HSBC sells $2.52 million trigger autocallable contingent yield notes on Merck
|
| 3/8/2017 | SP | HSBC plans trigger autocallable contingent yield notes on Merck
|
| 3/8/2017 | SP | New Issue: HSBC prices $1.6 million autocallable contingent income barrier notes on stocks
|
| 3/7/2017 | SP | JPMorgan to price digital contingent coupon CDs linked to 10 stocks
|
| 3/6/2017 | SP | Goldman Sachs plans to price variable-coupon CDs due 2024 on 10 stocks
|
| 3/6/2017 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2024 on 10 stocks
|
| 3/6/2017 | SP | Goldman Sachs Bank to price variable-coupon CDs due 2022 on 10 stocks
|
| 3/6/2017 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 2/14/2017 | SP | Wells Fargo plans variable annual interest CDs due 2024 on 10 stocks
|
| 2/13/2017 | SP | Goldman Sachs plans variable-coupon CDs due 2022 linked to 10 stocks
|
| 2/13/2017 | SP | Goldman Sachs plans variable-coupon CDs due 2024 linked to 10 stocks
|
| 2/13/2017 | SP | Goldman Sachs to price variable-coupon CDs due 2024 tied to 10 stocks
|
| 1/20/2017 | SP | New Issue: UBS sells $5.23 million trigger autocallable contingent yield notes on Merck
|
| 1/10/2017 | SP | UBS plans trigger autocallable contingent yield notes linked to Merck
|
| 1/10/2017 | SP | Bank of the West to sell contingent variable-income CDs on 10 stocks
|
| 1/9/2017 | SP | Wells Fargo plans variable annual interest CDs due 2024 on 10 stocks
|
| 12/16/2016 | SP | Wells Fargo to price variable annual interest CDs linked to 10 stocks
|
| 12/14/2016 | SP | New Issue: RBC prices $3 million of autocallable reverse convertibles on two stocks
|
| 12/9/2016 | SP | New Issue: BofA Finance prices $1.43 million contingent income autocallables linked to pharma stocks
|
| 12/2/2016 | SP | New Issue: Citigroup sells $664,000 contingent coupon autocallables tied to stocks
|
| 12/2/2016 | SP | New Issue: Citi prices $2 million contingent coupon autocallables on three stocks
|
| 11/16/2016 | SP | Citi plans autocallable contingent coupon equity notes on three stocks
|
| 11/10/2016 | SP | Wells Fargo to price variable annual interest CDs linked to 10 stocks
|
| 11/7/2016 | SP | Citigroup plans contingent coupon autocallables tied to three stocks
|
| 10/27/2016 | IG | Fitch rates Merck notes A
|
| 10/27/2016 | IG | S&P rates Merck notes AA
|
| 10/26/2016 | IG | Moody’s assigns A1 to Merck notes
|
| 10/10/2016 | SP | Wells Fargo to price variable annual interest CDs linked to 10 stocks
|
| 9/19/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 9/6/2016 | SP | New Issue: RBC prices $2 million contingent coupon barrier autocallables tied to two stocks
|
| 8/23/2016 | SP | New Issue: JPMorgan prices $5.29 million contingent interest autocallables linked to four stocks
|
| 8/10/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 8/3/2016 | SP | JPMorgan plans contingent interest autocallables tied to four stocks
|
| 7/11/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 7/5/2016 | SP | New Issue: HSBC prices $865,000 seven-year income plus notes tied to five stocks
|
| 7/5/2016 | SP | Bank of the West plans contingent variable-income CDs on 10 stocks
|
| 6/13/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 6/9/2016 | SP | HSBC plans income plus notes on five stocks with 6% potential coupon
|
| 6/3/2016 | SP | New Issue: HSBC prices $855,000 seven-year income plus notes tied to five stocks
|
| 5/24/2016 | SP | New Issue: HSBC prices $15 million income plus notes linked to five stocks
|
| 5/20/2016 | SP | HSBC plans income plus notes on five stocks with 1.5% minimum coupon
|
| 5/13/2016 | SP | HSBC plans income plus notes on five stocks with 6% potential coupon
|
| 5/10/2016 | SP | HSBC plans 0.25%-3.5% five-year Rate Builder CDs linked to 10 stocks
|
| 5/10/2016 | SP | HSBC plans 0.3%-5% seven-year Rate Builder CDs linked to 10 stocks
|
| 5/9/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 4/29/2016 | SP | New Issue: HSBC prices $1.21 million seven-year income plus notes on five stocks
|
| 4/11/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 4/4/2016 | SP | Bank of the West plans contingent variable-income CDs tied to stocks
|
| 3/29/2016 | SP | HSBC plans income plus notes on five stocks with 7% potential coupon
|
| 3/8/2016 | SP | Bank of the West plans contingent variable-income CDs linked to stocks
|
| 3/8/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 3/8/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 6.75% potential coupon
|
| 3/8/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 3% potential coupon
|
| 3/8/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 5% potential coupon
|
| 3/8/2016 | SP | HSBC plans Income Plus CDs tied to stocks with 4% potential coupon
|
| 3/3/2016 | SP | New Issue: HSBC prices $8.58 million income notes linked to basket of 20 stocks
|
| 2/12/2016 | SP | HSBC plans to price income notes linked to basket of 20 common stocks
|
| 2/11/2016 | SP | Morgan Stanley to price buffered return notes linked to 30 stocks
|
| 2/11/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 2/3/2016 | SP | Bank of the West plans contingent variable-income CDs linked to stocks
|
| 1/21/2016 | SP | New Issue: JPMorgan prices $394,000 trigger phoenix autocallables linked to Merck
|
| 1/14/2016 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 1/14/2016 | SP | JPMorgan plans five-year trigger phoenix autocallables tied to Merck
|
| 1/5/2016 | SP | Bank of the West plans contingent variable-income CDs linked to stocks
|
| 12/28/2015 | SP | New Issue: HSBC prices $523,000 seven-year income plus notes linked to five stocks
|
| 12/22/2015 | SP | Market Commentary: Potential higher rate offered by HSBC’s income plus notes on five stocks seen as hard to catch
|
| 12/21/2015 | SP | HSBC plans income plus notes on five stocks with 6.25% potential coupon
|
| 12/9/2015 | SP | New Issue: RBC prices $7.39 million autocallable reverse convertibles linked to three stocks
|
| 12/8/2015 | BKIG | Moody’s upgrades Merck debt to A1
|
| 12/7/2015 | SP | New Issue: HSBC prices $237,000 income plus notes linked to five stocks
|
| 11/18/2015 | SP | New Issue: Bank of America prices $2.5 million 9.7% autocallable yield notes linked to three stocks
|
| 11/11/2015 | SP | HSBC plans income plus notes on five stocks with 6.25% potential coupon
|
| 11/3/2015 | SP | Bank of the West plans seven-year income CDs linked to 10 stocks
|
| 10/30/2015 | SP | New Issue: HSBC prices $1.57 million income plus notes linked to five stocks
|
| 10/23/2015 | SP | New Issue: RBC prices $2.7 million bullish barrier enhanced notes on five stocks
|
| 10/20/2015 | SP | New Issue: RBC prices $410,000 bullish barrier enhanced notes linked to five stocks
|
| 10/19/2015 | SP | RBC plans 0% bullish barrier enhanced notes on basket of five stocks
|
| 10/16/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 10/15/2015 | SP | RBC plans bullish barrier enhanced return notes on five stocks
|
| 10/2/2015 | SP | Bank of the West plans seven-year income CDs linked to 10 stocks
|
| 10/1/2015 | SP | HSBC plans to price income plus notes linked to five stocks
|
| 9/11/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 9/11/2015 | SP | New Issue: JPMorgan prices $1 million contingent buffered notes tied to 11 stocks
|
| 9/10/2015 | SP | New Issue: Deutsche Bank prices $180,623 call warrants linked to 11 stocks
|
| 9/10/2015 | SP | New Issue: Deutsche Bank prices $5.96 million knock-out notes on stock basket
|
| 9/10/2015 | SP | New Issue: Credit Suisse prices $1.35 million knock-out notes linked Merck
|
| 9/8/2015 | SP | New Issue: Deutsche Bank prices $1.29 million knock-out notes on stock basket
|
| 8/13/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 8/12/2015 | SP | New Issue: Credit Suisse prices $490,000 trigger phoenix autocallable notes linked to Merck
|
| 8/5/2015 | SP | Credit Suisse plans trigger phoenix autocallable notes linked to Merck
|
| 8/4/2015 | SP | Bank of the West plans seven-year income CDs linked to 10 stocks
|
| 7/16/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 7/6/2015 | SP | Bank of the West plans seven-year income CDs linked to 10 stocks
|
| 7/1/2015 | SP | New Issue: Deutsche Bank prices $8.38 million absolute return knock-out notes linked to Merck
|
| 6/24/2015 | SP | Deutsche Bank plans capped absolute return knock-out notes on Merck
|
| 6/8/2015 | SP | Barclays Bank Delaware to price seven-year CDs linked to five stocks
|
| 6/8/2015 | SP | Barclays Bank Delaware to price six-year CDs linked to five stocks
|
| 6/8/2015 | SP | Barclays Bank Delaware to price five-year CDs linked to five stocks
|
| 6/8/2015 | SP | Barclays Bank Delaware to price three-year CDs linked to five stocks
|
| 5/19/2015 | SP | New Issue: Credit Suisse prices $602,500 trigger phoenix autocallables on Merck
|
| 5/13/2015 | SP | Credit Suisse to price trigger phoenix autocallables linked to Merck
|
| 5/11/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 5/8/2015 | SP | Barclays Bank Delaware to price three-year CDs linked to five stocks
|
| 5/8/2015 | SP | Barclays Bank Delaware to price five-year CDs linked to five stocks
|
| 5/8/2015 | SP | Barclays Bank Delaware to price six-year CDs linked to five stocks
|
| 5/8/2015 | SP | Barclays Bank Delaware plans seven-year CDs linked to five stocks
|
| 5/6/2015 | SP | Bank of the West plans seven-year income CDs linked to 10 stocks
|
| 4/13/2015 | IG | Fitch downgrades Merck IDR to A
|
| 3/9/2015 | SP | Wells Fargo plans variable annual interest CDs linked to 10 stocks
|
| 3/6/2015 | SP | Barclays Bank Delaware plans seven-year CDs linked to five stocks
|
| 3/6/2015 | SP | Barclays Bank Delaware plans six-year CDs linked to five stocks
|
| 3/6/2015 | SP | Barclays Bank Delaware plans five-year CDs linked to five stocks
|
| 3/2/2015 | IG | Market Commentary: Morning Commentary: Long bonds active in secondary; Williams, Microsoft, Merck mostly flat
|
| 2/24/2015 | SP | New Issue: JPMorgan prices $2.85 million trigger phoenix autocallables linked to Merck
|
| 2/23/2015 | CVLM | Merck gets no tenders in offer for three series of Cubist convertibles
|
| 2/19/2015 | SP | JPMorgan to price trigger phoenix autocallables linked to Merck
|
| 2/12/2015 | IG | Market Commentary: Morning Commentary: Investment-grade bonds mixed; Merck firms; Time Warner Cable mostly flat
|
| 2/11/2015 | IG | Market Commentary: Morning Commentary: Investment-grade bonds flat to better in early trade; Merck stable
|
| 2/10/2015 | IG | Market Commentary: Morning Commentary: High-grade bonds mixed in early trade; Merck mostly soft; spreads flat
|
| 2/6/2015 | EMHYMUPFPV | Market Commentary: Third Point eyes 10-year bond offering; supply tops $42 billion; Merck bonds trade tighter
|
| 2/6/2015 | IG | Market Commentary: Third Point eyes 10-year bond offering; supply tops $42 billion; Merck bonds trade tighter
|
| 2/6/2015 | IG | Fitch assigns A+ to Merck notes
|
| 2/6/2015 | IG | Market Commentary: Morning Commentary: Merck bonds trade better in secondary market; primary wraps $39 billion week
|
| 2/6/2015 | IG | New Issue: Merck details upsized $8 billion sale of senior notes in six tranches
|
| 2/5/2015 | EMHYMUPFPV | Market Commentary: Merck upsizes jumbo deal; Japan Finance, Costco price; Pfizer, Hospira active on acquisition
|
| 2/5/2015 | IG | Market Commentary: Merck upsizes jumbo deal; Japan Finance, Costco price; Pfizer, Hospira active on acquisition
|
| 2/5/2015 | IG | New Issue: Merck sells upsized $8 billion of senior notes in six tranches
|
| 2/5/2015 | IG | S&P rates Merck notes AA
|
| 2/5/2015 | IG | Moody’s assigns Merck notes A2
|
| 2/5/2015 | IG | Merck set to price $6 billion of notes in six tranches Thursday
|
| 1/22/2015 | CVLM | Merck tenders for three series of Cubist convertibles following merger
|
| 1/9/2015 | SP | Barclays Bank Delaware plans seven-year CDs on basket of five stocks
|
| 1/9/2015 | SP | Barclays Bank Delaware plans seven-year CDs linked to five stocks
|
| 1/9/2015 | SP | Barclays Bank Delaware plans five-year CDs linked to five stocks
|
| 12/31/2014 | LM | Outlook 2015: Merck, Simon Properties, CVS Caremark in big deals; M&A to impact deal flows
|
| 12/18/2014 | SP | New Issue: UBS prices $500,000 trigger phoenix autocallables linked to Merck
|
| 12/8/2014 | BKCVIG | Merck to issue $9.5 billion of debt to acquire Cubist Pharmaceuticals
|
| 12/5/2014 | IGLM | Merck’s Schering-Plough redeems all $1 billion 6% notes due 2017
|
| 12/1/2014 | SP | New Issue: RBC prices $2.12 million buffered optimization notes tied to health care stocks
|
| 11/6/2014 | SP | Barclays Bank Delaware plans five-year CDs linked to five stocks
|
| 11/6/2014 | SP | Barclays Bank Delaware plans six-year CDs linked to five stocks
|
| 11/6/2014 | SP | Barclays Bank Delaware plans five-year CDs linked to five stocks
|
| 10/22/2014 | SP | New Issue: Deutsche Bank prices $2.39 million trigger phoenix autocallables linked to Merck
|
| 10/15/2014 | IGLM | Merck takes in tenders for $1.8 billion of eight note series in offer
|
| 10/14/2014 | IGLM | Merck prices tender offers for $4.76 billion of eight note series
|
| 10/14/2014 | SP | Deutsche to price trigger phoenix autocallables linked to Merck
|
| 10/6/2014 | IG | Fitch assigns A+ to Merck notes
|
| 10/6/2014 | IG | Moody’s rates Merck notes A2
|
| 10/6/2014 | IG | S&P rates Merck euro notes AA
|
| 10/6/2014 | IGLM | Merck begins tender offers for $4.76 billion of eight note series
|
| 9/24/2014 | SP | JPMorgan plans five-year contingent coupon notes linked to 15 stocks
|
| 9/23/2014 | SP | New Issue: Deutsche Bank prices $1.45 million trigger autocallables linked to Merck
|
| 9/17/2014 | SP | Deutsche Bank plans trigger autocallable optimization notes on Merck
|
| 9/17/2014 | SP | JPMorgan plans five-year contingent coupon notes linked to 15 stocks
|
| 9/11/2014 | SP | JPMorgan plans five-year contingent coupon notes linked to 15 stocks
|
| 8/5/2014 | SP | New Issue: RBC prices $6.91 million 7.2% callable reverse convertibles linked to three stocks
|
| 7/9/2014 | SP | JPMorgan plans to price return notes linked to basket of 16 stocks
|
| 4/30/2014 | SP | New Issue: RBC prices $5.97 million 9.3% reverse convertibles linked to Yahoo!, Merck
|
| 4/25/2014 | IG | Fitch: Merck outlook negative
|
| 3/11/2014 | SP | New Issue: HSBC prices $7 million return enhanced notes linked to three stocks
|
| 3/5/2014 | SP | New Issue: HSBC prices $675,000 return enhanced notes linked to three stocks
|
| 2/27/2014 | SP | New Issue: HSBC prices $2.03 million return enhanced notes linked to three stocks
|
| 2/26/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
| 2/24/2014 | SP | New Issue: HSBC prices $1.7 million return enhanced notes linked to pharma stocks
|
| 2/20/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
| 2/20/2014 | SP | New Issue: HSBC prices $1.1 million knock-out buffer notes linked to basket of three stocks
|
| 2/20/2014 | SP | New Issue: HSBC prices $2.69 million return enhanced notes linked to three stocks
|
| 2/13/2014 | SP | HSBC to price knock-out buffer notes tied to basket of three stocks
|
| 2/11/2014 | SP | HSBC plans three-year return enhanced notes linked to three stocks
|
| 2/11/2014 | SP | New Issue: Deutsche Bank prices $445,000 return enhanced notes linked to pharma stocks
|
| 2/5/2014 | SP | New Issue: Deutsche Bank prices $1.26 million knock-out notes linked to three stocks
|
| 2/5/2014 | SP | New Issue: Deutsche Bank prices $4.23 million knock-out notes tied to three stocks
|
| 2/4/2014 | SP | New Issue: Deutsche Bank prices $3.42 million return enhanced notes linked to pharma stocks
|
| 1/29/2014 | SP | Deutsche Bank plans knock-out notes tied to basket of three stocks
|
| 1/29/2014 | SP | New Issue: HSBC prices $1.32 million income plus notes on stocks with 9.5% potential coupon
|
| 1/29/2014 | SP | New Issue: HSBC prices $200,000 income plus notes tied to stocks with 6.5% potential coupon
|
| 1/7/2014 | SP | Bank of the West to price income advantage CDs linked to five stocks
|
| 1/7/2014 | SP | Bank of the West to price income advantage CDs linked to stock basket
|
| 1/2/2014 | SP | HSBC plans income plus notes on stock basket with 1% minimum coupon
|
| 1/2/2014 | SP | HSBC plans income plus notes on stock basket with 1.5% minimum coupon
|
| 12/30/2013 | SP | New Issue: HSBC prices $1.4 million income plus notes on stocks with 9.8% potential coupon
|
| 12/30/2013 | SP | New Issue: HSBC prices $33,000 income plus notes tied to stocks with 6.75% potential coupon
|
| 12/4/2013 | SP | HSBC plans income plus notes tied to stocks with 5.5% potential coupon
|
| 12/4/2013 | SP | HSBC plans income plus notes tied to stocks with 9.5% potential coupon
|
| 11/25/2013 | SP | New Issue: HSBC prices $1.97 million income plus notes on stocks with 9.5% potential coupon
|
| 11/25/2013 | SP | New Issue: HSBC prices $376,000 income plus notes on five stocks with 5.5% potential coupon
|
| 11/19/2013 | SP | New Issue: Barclays prices $5 million trigger phoenix autocallables on Merck
|
| 11/13/2013 | SP | Barclays to price trigger phoenix autocallables linked to Merck
|
| 9/10/2013 | SP | New Issue: UBS prices $4.62 million trigger autocallable optimization securities on Merck
|
| 9/4/2013 | SP | UBS plans trigger autocallable securities linked to Merck
|
| 5/20/2013 | IG | Market Commentary: Midday Commentary: Merck notes trade tighter in high-grade secondary market
|
| 5/16/2013 | BKIG | Fitch rates Merck notes A+
|
| 5/16/2013 | IG | Market Commentary: Midday Commentary: Secondary market digests Merck's large offering, notes trade tighter
|
| 5/16/2013 | IG | New Issue: Merck details terms of $6.5 billion sale in six tranches
|
| 5/15/2013 | IG | S&P gives Merck notes AA
|
| 5/15/2013 | IG | Market Commentary: Merck sells in six parts; AmEx, Total System price; Merck deal in focus in secondary market
|
| 5/15/2013 | IG | Merck set to price large note offering in six tranches Wednesday
|
| 5/15/2013 | IG | New Issue: Merck prices $6.5 billion of notes in six tranches
|
| 5/15/2013 | IG | Moody's rates Merck notes A2
|
| 5/14/2013 | BKIG | Moody's downgrades Merck
|
| 5/3/2013 | IG | Fitch: Merck cut to negative
|
| 5/1/2013 | BKIG | Moody's may lower Merck
|
| 4/23/2013 | SP | New Issue: Barclays prices $3.57 million trigger phoenix autocallables linked to Merck
|
| 4/17/2013 | SP | Barclays plans to price trigger phoenix autocallables linked to Merck
|
| 2/20/2013 | SP | New Issue: Morgan Stanley prices $3.03 million market plus notes linked to Merck
|
| 12/3/2012 | IG | Merck files automatic shelf registration covering debt securities
|
| 9/10/2012 | BKIG | Fitch rates Merck notes A+
|
| 9/10/2012 | BKIG | Moody's rates Merck notes A1
|
| 9/10/2012 | IG | Merck intends to price notes in five-, 10-, 30-year maturities
|
| 9/10/2012 | IG | New Issue: Merck prices $2.5 billion of notes in five-, 10-, 30-year maturities
|
| 9/10/2012 | IG | Market Commentary: Walgreen, Transocean, ConAgra, Dominion sell in congested primary; HP active; new deals firm
|
| 9/10/2012 | BKIG | S&P rates Merck notes AA
|
| 6/4/2012 | BKIG | Moody's: Merck revolver A1
|
| 10/12/2011 | CVIG | Fitch affirms Merck
|
| 6/21/2011 | SP | New Issue: Morgan Stanley prices $910,000 knock-out notes linked to Merck
|
| 6/20/2011 | PF | Moody's rates Merck loan A1
|
| 6/20/2011 | CVIG | Moody's rates Merck loans A1
|
| 6/14/2011 | SP | Morgan Stanley plans to price knock-out notes tied to Merck stock
|
| 3/22/2011 | SP | New Issue: JPMorgan prices $2.91 million daily observation knock-out notes on Merck
|
| 3/16/2011 | SP | Market Commentary: JPMorgan's daily observation knock-out notes on Merck target bulls seeking unlimited upside
|
| 3/15/2011 | SP | JPMorgan plans daily observation knock-out notes linked to Merck
|
| 12/13/2010 | IGPF | Fitch rates Merck notes A+
|
| 12/7/2010 | IG | Market Commentary: Merck brings massive sale; Berkshire, Albemarle, Aspen price; financials firm; IBM tightens
|
| 12/7/2010 | IG | New Issue: Merck sells $2 billion of notes in five-, 10-year maturities
|
| 12/7/2010 | IG | Moody's rates Merck notes A1
|
| 11/29/2010 | SP | HSBC Bank to sell "all up" CDs with minimum coupon tied to five stocks
|
| 11/24/2010 | IGPF | S&P upgrades Merck
|
| 10/13/2010 | IGPF | Fitch affirms Merck
|
| 8/19/2010 | SP | New Issue: Credit Suisse sells $500,000 contingent coupon autocallable notes on five stocks
|
| 8/12/2010 | CV | Market Commentary: EMC, NetApp under pressure; SunPower better on earnings; A&P steady; Petrominerales prices
|
| 8/12/2010 | CVLMPF | Merck says its 6% convertible preferreds will be converted on Friday
|
| 7/21/2010 | SPSW | Issuance doubles to $860 million; appetite grows for innovation, complexity in volatile market
|
| 7/19/2010 | SP | New Issue: Barclays prices $16.22 million autocallable optimization securities on Merck via UBS
|
| 7/13/2010 | SP | Barclays plans autocallable optimization securities on Merck via UBS
|
| 6/24/2010 | IG | Moody's assigns Merck loan A1
|
| 6/23/2010 | SPSW | Issuance rises, autocallables jump to nearly a third of total volume
|
| 6/16/2010 | SP | New Issue: UBS prices $16.78 million autocallable optimization securities linked to Merck
|
| 6/11/2010 | SP | UBS to price autocallable optimization securities linked to Merck
|
| 5/19/2010 | SPSW | Volume doubles to $887 million while single-stock, reverse convertible deals make strong push
|
| 5/13/2010 | SP | New Issue: JPM prices $21.06 million autocallable optimization securities linked to Merck via UBS
|
| 5/4/2010 | SP | JPMorgan plans autocallable optimization notes on Merck stock via UBS
|
| 11/17/2009 | IG | Moody's rates Merck program Prime-1, loan Aa3
|
| 11/5/2009 | IG | Moody's affirms Merck, ups Schering-Plough
|
| 11/5/2009 | IG | S&P affirms Merck, lifts Schering-Plough
|
| 11/4/2009 | IG | Fitch cuts Merck, ups Schering-Plough
|
| 10/29/2009 | SS | Merck, Schering-Plough merger granted additional regulatory approvals
|
| 10/23/2009 | SS | Merck, Schering-Plough merger expected to close in fourth quarter
|
| 9/29/2009 | SP | New Issue: Barclays prices $5 million 8.25% reverse convertibles linked to Merck
|
| 9/14/2009 | SS | Market Commentary: Merck deal targeted for November close; Sprint stock up on bid rumors; Patheon snubs JLL
|
| 9/10/2009 | SP | Barclays to price 8.25% reverse convertibles linked to Merck
|
| 9/1/2009 | SP | New Issue: Credit Suisse prices $27.51 million 10% equity-linked notes linked to Merck
|
| 8/31/2009 | SP | New Issue: Barclays prices $4 million 9% reverse convertibles linked to Merck
|
| 8/7/2009 | SS | Market Commentary: Merck awaits end of reviews; IPC buyout may hinge on weather; FTC clears Watson Wyatt merger
|
| 8/7/2009 | SP | Barclays to price 9% reverse convertibles linked to Merck
|
| 8/7/2009 | SS | Merck, Schering-Plough shareholders OK proposed stock-and-cash deal
|
| 8/6/2009 | SS | Market Commentary: Canadian Hydro urges against offer; Terra bid clears review; Schering to air deal vote
|
| 6/26/2009 | IG | Market Commentary: Campbell Soup, Credit Suisse branch sell bonds, KfW reopens; week ahead top heavy; Merck eyed
|
| 6/25/2009 | SS | Merck, Schering-Plough shareholders to decide merger on Aug. 7
|
| 6/25/2009 | IG | Market Commentary: Citigroup, Jefferies, Analog Devices, MassMutual, Torchmark sell notes; Merck busy, up again
|
| 6/24/2009 | IG | Market Commentary: Time Warner Cable, Omnicom, Enogex price deals early; spreads tighter, Merck bonds firmer
|
| 6/23/2009 | IG | Market Commentary: Virginia Electric & Power, Danske Bank, Gulf Power sell bonds; new deals mostly trade higher
|
| 6/22/2009 | IG | Fitch rates Merck notes AA-
|
| 6/22/2009 | IG | Market Commentary: Merck sells mega-deal, Telefonica Emisiones, Gulf Power sell bonds; deals firm in secondary
|
| 6/22/2009 | SS | Market Commentary: Regulators eye Merck, Fidelity; Anglo American may be ripe for pact; Tower needs investor OK
|
| 6/22/2009 | IG | Drug maker Merck files debt securities automatic shelf registration
|
| 6/22/2009 | IG | New Issue: Merck prices upsized $4.25 billion notes in four tranches
|
| 6/22/2009 | IG | Moody's rates Merck notes Aa3
|
| 6/17/2009 | SP | New Issue: Wachovia prices $2.73 million 12.5% enhanced yield notes linked to Merck for Eksportfinans
|
| 6/16/2009 | SS | Market Commentary: Analyst: Sell Data Domain equity now; Merck, Schering meetings set; GM inks deal to sell Saab
|
| 6/1/2009 | SP | Wachovia to price 10%-12% enhanced yield notes linked to Merck for Eksportfinans
|
| 5/28/2009 | SP | New Issue: ABN Amro prices $0.383 million 13.25% reverse convertibles linked to Merck
|
| 5/28/2009 | SS | Johnson & Johnson tries to cancel distribution agreement with Schering
|
| 5/8/2009 | SP | ABN Amro plans 13.25% reverse exchangeables linked to Merck stock
|
| 4/29/2009 | SP | New Issue: ABN Amro prices $0.387 million 14.25% reverse convertibles linked to Merck
|
| 4/14/2009 | SP | ABN Amro plans to price 14.25% reverse exchangeables linked to Merck
|
| 3/24/2009 | IG | Moody's: Merck unaffected
|
| 3/18/2009 | SS | Market Commentary: Sun Microsystems stock surges; NRG takes legal action; J&J might challenge Schering-Plough merger
|
| 3/17/2009 | SS | Market Commentary: Wyeth shares play catch-up to Pfizer bid; Exelon, NRG spar; Merck, Schering-Plough timing eyed
|
| 3/13/2009 | IG | Merck, Schering-Plough plan multi-tranche bond offering to pay down loans
|
| 3/11/2009 | SS | Market Commentary: Johnson & Johnson a thorn in Merck deal; Nobel Learning gets cheap bid; sale likely for Charlotte Russe
|
| 3/10/2009 | SS | Market Commentary: Merck merger hinges on regulatory OKs; Rohm gains from Dow's tardiness; United Tech on the hunt
|
| 3/9/2009 | IG | Moody's affirms Merck; outlook negative
|
| 3/9/2009 | IG | Fitch: Merck pressured
|
| 3/9/2009 | SS | Merck to buy Schering-Plough for $41.1 billion in cash, stock
|
| 3/9/2009 | SS | Market Commentary: Merck plows over Schering-Plough; Dow, Rohm & Haas settle; Genentech wants more from Roche
|
| 3/9/2009 | CVIG | S&P: Schering-Plough on positive watch
|
| 2/17/2009 | SP | Barclays to price 10.7% reverse convertibles linked to Merck
|
| 2/12/2009 | SS | Market Commentary: Dow dividend cut no relief for Rohm; Cisco, VMware deal not in the cards; PharmaNet buyout a low risk
|
| 1/29/2009 | SP | New Issue: Barclays prices $1.5 million 13.5% reverse convertibles linked to Merck
|
| 1/21/2009 | SP | RBC to price 12.75% RevCons linked to Merck
|
| 1/16/2009 | SP | Barclays to price 13.5% reverse convertibles linked to Merck
|
| 12/23/2008 | SP | New Issue: Barclays prices $1 million 12% reverse convertibles linked to Merck
|
| 12/16/2008 | SP | Barclays to price 12% reverse convertibles linked to Merck
|
| 11/17/2008 | IG | Fitch affirms Merck; outlook negative
|
| 11/12/2008 | SP | RBC plans 10.4% reverse convertibles linked to Merck
|
| 10/17/2008 | SP | Barclays to price 14% reverse convertibles linked to Merck
|
| 10/17/2008 | SP | ABN Amro plans 12.75% Knock-in Reverse Exchangeables linked to Merck
|
| 9/26/2008 | SP | New Issue: Barclays prices $3 million 8.75% reverse convertibles linked to Merck
|
| 9/12/2008 | SP | Barclays to price 8.75% reverse convertibles linked to Merck
|
| 9/11/2008 | SP | Morgan Stanley to price 10%-12% RevCons linked to Merck
|
| 8/28/2008 | SP | New Issue: Barclays prices $4 million 9.75% reverse convertibles linked to Merck
|
| 8/13/2008 | SP | Barclays to price 9.75% reverse convertibles linked to Merck
|
| 7/30/2008 | SP | New Issue: ABN Amro prices $0.35 million 12.25% reverse convertibles linked to Merck
|
| 7/30/2008 | SP | New Issue: Barclays prices $3.5 million 10% reverse convertibles linked to Merck
|
| 7/11/2008 | SP | Barclays to price 10% reverse convertibles linked to Merck
|
| 7/9/2008 | SP | ABN Amro plans 12.25% knock-in notes linked to Merck
|
| 6/27/2008 | SP | New Issue: Barclays prices $6 million 9% reverse convertibles linked to Merck
|
| 6/10/2008 | SP | Barclays to price 9% reverse convertibles linked to Merck
|
| 6/10/2008 | SP | UBS to price 0% autocallable optimization securities linked to Merck
|
| 5/30/2008 | SP | New Issue: ABN Amro prices $0.45 million 12.25% reverse convertibles linked to Merck
|
| 5/29/2008 | SP | New Issue: Barclays prices $6.5 million 10% reverse convertibles linked to Merck
|
| 5/29/2008 | SP | New Issue: JPMorgan prices $354,000 9.5% reverse exchangeables linked to Merck
|
| 5/20/2008 | SP | New Issue: Wachovia prices $10 million 9.25% enhanced yield notes linked to Merck for Eksportfinans
|
| 5/9/2008 | SP | Barclays to price 10% reverse convertibles linked to Merck
|
| 5/7/2008 | SP | ABN Amro plans 12.25% knock-in notes linked to Merck
|
| 5/7/2008 | SP | New Issue: Barclays prices $4.5 million 11% reverse convertibles linked to Merck
|
| 5/7/2008 | SP | Fortis to price 17.25% knock-in reverse convertibles linked to worst of 'Small Dogs' basket
|
| 5/6/2008 | SP | JPMorgan to price 9.5% reverse exchangeables linked to Merck
|
| 5/5/2008 | SP | Wachovia to price enhanced yield securities linked to Merck for Eksportfinans
|
| 4/30/2008 | SP | New Issue: ABN Amro prices $1.5 million 12.5% reverse convertibles linked to Merck
|
| 4/30/2008 | SP | New Issue: ABN Amro prices $500,000 9.25% reverse convertibles linked to Merck
|
| 4/29/2008 | SP | New Issue: JPMorgan prices $1.79 million 10% reverse exchangeables linked to Merck
|
| 4/29/2008 | SP | New Issue: Barclays prices $4.5 million 11% reverse convertibles linked to Merck
|
| 4/15/2008 | SP | New Issue: Citigroup prices $35.53 million 10% ELKS linked to Merck
|
| 4/8/2008 | SP | Barclays to price 11% reverse convertibles linked to Merck
|
| 4/8/2008 | SP | Barclays to price 8.75% reverse convertibles linked to Merck
|
| 4/8/2008 | SP | JPMorgan to price 10% reverse exchangeables linked to Merck
|
| 4/7/2008 | SP | Citigroup to price 9.75% to 10.75% ELKS linked to Merck
|
| 4/7/2008 | SP | ABN Amro plans 12.5% Knock-in Reverse Exchangeables linked to Merck
|
| 3/28/2008 | SP | New Issue: ABN Amro prices $1.4 million 13.6% reverse convertibles linked to Merck
|
| 3/28/2008 | SP | New Issue: Barclays prices $4 million 9.25% reverse convertibles linked to Merck
|
| 3/28/2008 | SP | New Issue: Barclays prices $3 million 9.5% reverse convertibles linked to Merck
|
| 3/27/2008 | SP | New Issue: UBS prices $9.37 million 10.75% yield optimization notes linked to Merck
|
| 3/11/2008 | SP | Barclays to price 9.5% reverse convertibles linked to Merck
|
| 3/10/2008 | SP | Barclays to price 9.25% reverse convertibles linked to Merck
|
| 3/6/2008 | SP | ABN Amro to price 13.6% reverse exchangeables linked to Merck
|
| 3/5/2008 | SP | UBS to price 9.5%-11% yield optimization notes linked to Merck
|
| 2/29/2008 | SP | New Issue: JPMorgan prices $602,000 10% reverse exchangeables linked to Merck
|
| 2/28/2008 | SP | New Issue: Barclays prices $5 million 9.75% reverse convertibles linked to Merck
|
| 2/28/2008 | SP | New Issue: Barclays prices $4 million 9.25% reverse convertibles linked to Merck
|
| 2/26/2008 | SP | New Issue: Barclays prices $1 million principal-protected notes linked to Merck
|
| 2/20/2008 | SP | Barclays to price principal-protected notes linked to Merck
|
| 2/15/2008 | SP | New Issue: ABN Amro prices $50,000 12.75% reverse convertibles linked to Merck
|
| 2/11/2008 | SP | JPMorgan to price 10% reverse exchangeables linked to Merck
|
| 2/11/2008 | SP | New Issue: ABN Amro prices $1.6 million 12.75% reverse convertibles linked to Merck
|
| 2/11/2008 | SP | Barclays to price 9.25% reverse convertibles linked to Merck
|
| 2/8/2008 | SP | SG Structured Products to price 10.35% ReConvs linked to Merck
|
| 2/6/2008 | SP | Barclays to price 9.75% reverse convertibles linked to Merck
|
| 2/5/2008 | SP | ABN Amro to price 12.75% knock-in notes linked to Merck
|
| 1/16/2008 | CVIG | S&P: Schering-Plough unaffected
|
| 11/13/2007 | IG | Fitch affirms Merck
|
| 11/9/2007 | IG | Moody's: Merck outlook developing
|
| 11/9/2007 | IG | Market Commentary: Japan Bank plans global bonds; market slows to crawl ahead of holiday
|
| 10/30/2007 | SP | New Issue: Barclays prices $2 million 10.25% reverse convertibles linked to Merck
|
| 10/29/2007 | IG | S&P ups Merck outlook to stable
|
| 10/10/2007 | SP | Barclays to price 10.25% reverse convertibles linked to Merck
|
| 10/9/2007 | SP | Lehman to issue 9.6% reverse exchangeables linked to Merck
|
| 9/27/2007 | SP | New Issue: Lehman prices $500,000 9.65% reverse exchangeables linked to Merck
|
| 9/11/2007 | SP | Lehman to price 9.65% reverse exchangeables linked to Merck
|
| 8/31/2007 | SP | New Issue: Barclays prices $2.5 million 10% reverse convertibles linked to Merck
|
| 8/30/2007 | SP | New Issue: ABN Amro prices $300,000 13.8% reverse exchangeables linked to Merck
|
| 8/8/2007 | SP | Barclays to price 10% reverse convertibles linked to Merck
|
| 8/2/2007 | SP | ABN Amro to price 13.8% knock-in notes linked to Merck
|
| 7/27/2007 | SP | New Issue: UBS prices $6.5 million 8.45% yield optimization notes linked to Merck
|
| 7/26/2007 | SP | Rabobank to price 9% knock-in reverse convertibles linked to Merck
|
| 7/2/2007 | SP | UBS to price yield optimization notes linked to Merck
|
| 3/29/2007 | SP | New Issue: ABN Amro sells $875,000 10% Knock-in Reverse Exchangeables linked to Merck
|
| 3/2/2007 | SP | ABN Amro to price 10% knock-in reverse notes linked to Merck
|
| 11/10/2006 | BT | Moody's rates Merck loan, notes Aa3
|
| 11/10/2006 | BT | S&P rates Merck notes AA-
|
| 11/8/2006 | BT | S&P: Merck unaffected
|
| 10/31/2006 | BT | Market Commentary: Alnylam, CytRx gain with Sirna; Antigenics gains; Viragen sinks; ZymoGenetics off ahead of results
|
| 10/30/2006 | BT | Market Commentary: Sirna soars after hours on Merck $1.1 billion buyout; Emisphere plunges 24%; Point better by 19%
|
| 10/23/2006 | BT | Bear Stearns ups estimates for Merck
|
| 10/18/2006 | BT | Merck at peer perform by Bear Stearns
|
| 10/12/2006 | BT | Ambrilia Biopharma grants Merck worldwide rights to HIV/AIDS protease inhibitor program
|
| 9/25/2006 | BT | Arena, Merck end atherosclerosis drug development
|
| 9/14/2006 | BT | Merck: Data show glucose-lowering efficacy of Januvia in type 2 diabetes
|
| 9/7/2006 | BTCV | New Issue: ABN Amro sells $460,000 8% knock-in reverse notes linked to Merck
|
| 9/6/2006 | BTCV | New Issue: ABN Amro sells $350,000 8% knock-in reverse notes linked to Merck
|
| 8/28/2006 | CV | ABN Amro plans issue of 8% knock-in reverse convertibles linked to Merck
|
| 8/23/2006 | BT | Merck's Vioxx successor Arcoxia shows similar cardiovascular risk to diclofenac
|
| 8/17/2006 | BT | Merck says 24-week data shows effectiveness of MK-0518 in reducing HIV viral RNA
|
| 8/11/2006 | BT | Gilead, Merck to distribute Atripla in developing countries
|
| 7/31/2006 | BT | Merck says FDA to review diabetes therapy NDA
|
| 7/28/2006 | BT | Merck's Gardasil gets positive opinion from European Medicines Agency
|
| 7/24/2006 | BT | Merck: second-quarter worldwide sales up 6% at $5.8 billion
|
| 7/13/2006 | BT | S&P: Pfizer, Merck likely unchanged
|
| 7/11/2006 | BT | Merck's anti-nausea therapy Emend gets FDA approval
|
| 7/6/2006 | BT | Actelion, Merck renin alliance achieves third milestone
|
| 7/6/2006 | BT | Alnylam, Merck amend agreement to develop RNAi therapeutics
|
| 6/29/2006 | BT | Merck: CDC recommends cervical cancer vaccinations in young women with Gardasil
|
| 6/21/2006 | BT | Merck, Lundbeck say higher-dose gaboxadol shows deep-sleep potential
|
| 6/19/2006 | BT | Merck/Schering-Plough: Vytorin lowers 'bad' cholesterol better than Crestor
|
| 6/13/2006 | BT | Merck's Januvia demonstrates glucose-lowering effect in type 2 diabetes
|
| 6/12/2006 | BT | Merck: Januvia as monotherapy reduces blood sugar levels in phase 3 studies
|
| 6/12/2006 | BT | Merck/Schering-Plough: Vytorin superior to Lipitor in diabetic patients
|
| 6/12/2006 | BT | Sunesis gets $4.25 million milestone payment from Merck
|
| 6/9/2006 | BT | FDA approves new indication for Merck/Schering-Plough's cholesterol-lowering drug
|
| 6/8/2006 | BT | Merck's cervical cancer vaccine Gardasil approved by FDA
|
| 6/7/2006 | BT | Merck's Zolinza for T-cell lymphoma granted priority review
|
| 6/5/2006 | BT | Merck says phase 2b study points to benefit of Zolinza for T-cell lymphoma
|
| 6/5/2006 | BT | Merck plans to file New Drug Application for MK-0431A to treat diabetes this year
|
| 5/26/2006 | BT | Merck's Zostavax approved as shingles-prevention treatment
|
| 5/15/2006 | BT | Sentigen files agreement with Merck
|
| 5/11/2006 | BT | Merck releases preliminary analyses of off-drug extension of Vioxx study
|
| 5/9/2006 | BT | Merck to acquire Abmaxis for $80 million, GlycoFi for $400 million
|
| 5/1/2006 | BT | Market Commentary: Teva shares, convertibles gain on Zocor ruling; NeoPharm off amid downsizing; Alnylam, Idenix drop
|
| 4/20/2006 | BT | Merck first-quarter net income up, worldwide sales top $5.4 billion
|
| 4/20/2006 | BT | Moody's affirms Merck
|
| 4/6/2006 | BT | Credit Suisse puts Merck at neutral
|
| 4/4/2006 | BT | Merck predicts higher-than-expected first-quarter results
|
| 3/21/2006 | BT | NicOx, Merck to collaborate on antihypertensive drug development
|
| 3/20/2006 | BT | Neuromed, Merck to collaborate on novel N-type calcium channel compounds for pain
|
| 3/13/2006 | BT | Merck/Schering-Plough says Vytorin lowers 'bad' cholesterol more than Zocor
|
| 3/7/2006 | BT | Merck reduces price of Stocrin for HIV/AIDS patients in least-developed countries
|
| 3/2/2006 | BT | Merck terminates deal with Nastech to develop PYY3-36 nasal spray for obesity
|
| 2/24/2006 | BT | Merck's FDA review date for investigational shingles vaccine extended
|
| 2/21/2006 | BT | Merck's Rotateq rotavirus vaccine added to childhood immunization schedule
|
| 2/15/2006 | BT | Merck announces FDA accepts application for diabetes drug Januvia
|
| 2/9/2006 | BT | Merck's MK-0518 reduces viral load during phase 2 HIV study
|
| 2/3/2006 | BT | FDA approves Merck's Rotateq to prevent rotavirus gastroenteritis
|
| 2/2/2006 | BT | Fitch affirms Merck
|
| 1/17/2006 | BT | ChemGenex signs new deal with Merck for preclinical support in diabetes research
|
| 1/11/2006 | BT | Merck's Emend approved by FDA to prevent nausea, vomiting after chemotherapy
|
| 1/4/2006 | BT | Merck's rotavirus vaccine 98% effective, study says
|
| 12/22/2005 | BT | Bristol-Myers, Merck end collaboration on diabetes drug muraglitazar
|
| 12/20/2005 | BT | Merck, Indian Council of Medical Research collaborate on cervical cancer vaccine Gardasil
|
| 12/19/2005 | BT | Market Commentary: Pfizer, other Big Pharmas zoom; generic names Barr, Teva plunge; Cubist, Rigel, Xoma, Lexicon off
|
| 12/15/2005 | BT | Merck announces new research and development plan to save another $1 billion
|
| 12/15/2005 | BT | FDA advisers recommend Merck's shingles vaccine for adults over 60, but not for ages 50 through 59
|
| 12/14/2005 | BT | Merck's Rotateq rotavirus vaccine deemed safe, effective by FDA advisory committee
|
| 12/12/2005 | BT | Market Commentary: MedImmune up on flu drug data; Merck stock off on Vioxx mistrial; Encysive falls on Myogen's gain
|
| 12/8/2005 | BT | Merck, PATH to collaborate on rotavirus vaccine trials
|
| 12/7/2005 | BT | Vertex reaches milestone in collaboration with Merck to develop cancer treatments
|
| 12/5/2005 | BT | Merck applies for Biologics License Application for HPV vaccine Gardasil
|
| 11/30/2005 | BT | Market Commentary: Adams secondary launched; Isis off; Durect up; Inspire, BioCryst rocket up; Merck bonds weaker
|
| 11/28/2005 | BT | Merck announces cost-savings plan with focus on manufacturing and 7,000 job cuts
|
| 11/28/2005 | BT | Market Commentary: Merck pressures biotech sector; Amgen, Genentech lead slide; Enzon, BioCryst, Pozen up a tad
|
| 11/22/2005 | BT | Moody's assigns negative outlook to pharmaceutical industry
|
| 11/18/2005 | BT | Merck antiviral drug MK-0518 reduces HIV viral load by 98%, study says
|
| 11/8/2005 | BT | Vical gets $1 million payment as Merck advances cancer vaccine to phase I trial
|
| 11/3/2005 | BT | Moody's rates Merck unit Cloverleaf Prime-1
|
| 11/3/2005 | BT | Market Commentary: Abgenix, Amgen stocks take off on successful phase III study; Merck wins legal battle over Vioxx
|
| 11/2/2005 | BT | NicOx, Merck extend research collaboration, broaden scope
|
| 10/31/2005 | BT | Merck, Bristol-Myers license anti-HIV compounds to non-profit for use in poor countries
|
| 10/28/2005 | BTCV | New Issue: Barclays sells $4 million 9% exchangeables linked to Merck
|
| 8/30/2005 | BTCV | New Issue: Barclays sells $15 million 8.5% exchangeables linked to Merck
|
| 8/29/2005 | BT | S&P finds second quarter uneventful for Big Pharma outside Merck's Vioxx verdict
|
| 8/29/2005 | BT | Market Commentary: AtheroGenics, Amylin Pharma, Alpharma extend gains on takeover chatter; Pfizer, Merck credit mixed
|
| 8/23/2005 | BT | Moody's affirms Merck
|
| 8/23/2005 | BT | Fitch says Merck unaffected
|
| 8/23/2005 | BT | Market Commentary: Amylin stock, convertibles zoom on drug data; OSI rebounds; Merck credit finds buyers; Wyeth sold off
|
| 8/22/2005 | BT | S&P: Merck unaffected
|
| 8/19/2005 | BT | Market Commentary: Quintiles tapping bond market for $150 million; Merck spirals on Vioxx verdict; Vyteris taps PIPEs
|
| 8/18/2005 | BTCV | New Issue: ABN Amro sells $2.7 million 8% reverse exchangeables linked to Merck
|
| 6/23/2005 | BTCV | New Issue: ABN Amro sells $4.9 million of 9% reverse exchangeables linked to Merck
|
| 6/17/2005 | BT | Market Commentary: Mylan Labs bond deal surfaces; Vertex up, Merck lags; Genentech rises; stem cell names watched
|
| 3/15/2005 | CV | New Issue: Barclays sells $2.01 million 9% exchangeables linked to Merck
|
| 3/2/2005 | CV | New Issue: ABN Amro sells $2.25 million 9% reverse exchangeables linked to Merck & Co.
|
| 2/15/2005 | CV | New Issue: Goldman Sachs prices $20 million 7.4% trigger notes exchangeable for Merck
|
| 2/15/2005 | CV | New Issue: Goldman Sachs prices $20 million 6.8% trigger notes exchangeable for Merck
|
| 12/22/2004 | CV | New Issue: Barclays sells $4.864 million 9.05% reverse exchangeables linked to Merck
|
| 10/7/2004 | CV | New Issue: Goldman prices $8.25 million notes exchangeable for Merck
|
| 3/24/2003 | CV | New Issue: Merrill Lynch sells $25 million 6% Strides payable with Merck
|
